{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:13:11Z","timestamp":1778245991316,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017621","name":"Shenzhen Key Laboratory Formation Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.tube.2023.102336","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T16:33:41Z","timestamp":1678552421000},"page":"102336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["In vitro activity of tetracycline analogs against multidrug-resistant and extensive drug resistance clinical isolates of Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"140","author":[{"given":"Chi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingfeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dachuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2023.102336_bib1","series-title":"Global tuberculosis report 2018","year":"2019"},{"issue":"9","key":"10.1016\/j.tube.2023.102336_bib2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017863","article-title":"Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis","volume":"5","author":"Seung","year":"2015","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"10.1016\/j.tube.2023.102336_bib3","first-page":"516","volume":"vol. 38","author":"Falzon","year":"2011"},{"issue":"2","key":"10.1016\/j.tube.2023.102336_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1749-6632.1948.tb27262.x","article-title":"Aureomycin: a product of the continuing search for new antibiotics","volume":"51","author":"Duggar","year":"1948","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.tube.2023.102336_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.111.2874.85.a","article-title":"Terramycin, a new antibiotic","author":"Finlay","year":"1950","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.tube.2023.102336_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.1950.02910360003001","article-title":"Clinical observations on the use of Terramycin hydrochloride","volume":"143","author":"King","year":"1950","journal-title":"J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.tube.2023.102336_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6976.1996.tb00251.x","article-title":"Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution","volume":"19","author":"Roberts","year":"1996","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"10.1016\/j.tube.2023.102336_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2011.06354.x","article-title":"The history of the tetracyclines","volume":"1241","author":"Nelson","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.tube.2023.102336_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1021\/jm00027a023","article-title":"A new generation of potent antibacterial agents through modification of 9-aminotetracyclines","volume":"37","author":"Sum","year":"1994","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.tube.2023.102336_bib10","first-page":"789","article-title":"Tetracyclines","volume":"79","author":"Klein","year":"1995","journal-title":"Med Clin"},{"issue":"7","key":"10.1016\/j.tube.2023.102336_bib11","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0092-8674(00)00216-6","article-title":"The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit","volume":"103","author":"Brodersen","year":"2000","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.tube.2023.102336_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/10409230903307311","article-title":"The A\u2013Z of bacterial translation inhibitors","volume":"44","author":"Wilson","year":"2009","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"3","key":"10.1016\/j.tube.2023.102336_bib13","doi-asserted-by":"crossref","first-page":"C539","DOI":"10.1152\/ajpcell.00047.2010","article-title":"Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature","volume":"299","author":"Griffin","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"issue":"9","key":"10.1016\/j.tube.2023.102336_bib14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1164\/rccm.201110-1769OC","article-title":"Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases","volume":"185","author":"Walker","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.tube.2023.102336_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s10096-004-1268-4","article-title":"Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy","volume":"24","author":"Balabanova","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.tube.2023.102336_bib16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ijantimicag.2014.11.017","article-title":"Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis","volume":"45","author":"Gonzalo","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.tube.2023.102336_bib17","first-page":"367","article-title":"Antituberculous activity of tetracycline and related compounds","volume":"72","author":"Hobby","year":"1955","journal-title":"Am Rev Tuberc Pulm Dis"},{"issue":"2","key":"10.1016\/j.tube.2023.102336_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Irith","year":"2008","journal-title":"Nat Protoc"},{"issue":"22","key":"10.1016\/j.tube.2023.102336_bib19","doi-asserted-by":"crossref","first-page":"12712","DOI":"10.1073\/pnas.231275498","article-title":"Comprehensive identification of conditionally essential genes in mycobacteria","volume":"98","author":"Sassetti","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.tube.2023.102336_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/jb.176.2.535-539.1994","article-title":"Efficient transposition in mycobacteria: construction of Mycobacterium smegmatis insertional mutant libraries","volume":"176","author":"Guilhot","year":"1994","journal-title":"J Bacteriol"},{"key":"10.1016\/j.tube.2023.102336_bib21","series-title":"Mycobacteria protocols","author":"Parish","year":"2008"},{"issue":"6","key":"10.1016\/j.tube.2023.102336_bib22","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1128\/AEM.71.6.3077-3084.2005","article-title":"Use of a tetracycline-inducible system for conditional expression in Mycobacterium tuberculosis and Mycobacterium smegmatis","volume":"71","author":"Paul","year":"2005","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"10.1016\/j.tube.2023.102336_bib23","first-page":"311","article-title":"In vitro effect of tigecycline against Mycobacterium tuberculosis and a review of the available drugs for tuberculosis","volume":"5","author":"Coban","year":"2011","journal-title":"Afr J Microbiol Res"},{"issue":"2","key":"10.1016\/j.tube.2023.102336_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.tube.2023.102336_bib25","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1128\/AAC.49.4.1622-1625.2005","article-title":"Pharmacokinetics of oral doxycycline during combination treatment of severe falciparum malaria","volume":"49","author":"Newton","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"45","key":"10.1016\/j.tube.2023.102336_bib26","doi-asserted-by":"crossref","first-page":"33910","DOI":"10.1074\/jbc.M604724200","article-title":"Biochemistry of the initial steps of mycothiol biosynthesis","volume":"281","author":"Newton","year":"2006","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.tube.2023.102336_bib27","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1128\/AAC.00564-11","article-title":"Coresistance to isoniazid and ethionamide maps to mycothiol biosynthetic genes in Mycobacterium bovis","volume":"55","author":"Vilcheze","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.tube.2023.102336_bib28","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1128\/AAC.00020-11","article-title":"Precise null deletion mutations of the mycothiol synthesis genes reveal their role in isoniazid and ethionamide resistance in Mycobacterium smegmatis","volume":"55","author":"Xia","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.tube.2023.102336_bib29","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1365-2958.2008.06365.x","article-title":"Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis","volume":"69","author":"Vilch\u00e8ze","year":"2008","journal-title":"Mol Microbiol"},{"issue":"5661","key":"10.1016\/j.tube.2023.102336_bib30","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1126\/science.1094114","article-title":"The structure of a mycobacterial outer-membrane channel","volume":"303","author":"Michael","year":"2004","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.tube.2023.102336_bib31","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1128\/AAC.48.11.4163-4170.2004","article-title":"Multidrug resistance of a porin deletion mutant of Mycobacterium smegmatis","volume":"48","author":"Joachim","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.tube.2023.102336_bib32","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1128\/AAC.00239-08","article-title":"Role of porins for uptake of antibiotics by Mycobacterium smegmatis","volume":"52","author":"Danilchanka","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.tube.2023.102336_bib33","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/AEM.02492-10","article-title":"Importance of porins for biocide efficacy against Mycobacterium smegmatis","volume":"77","author":"Frenzel","year":"2011","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"10.1016\/j.tube.2023.102336_bib34","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/JB.01474-06","article-title":"Expression of the major porin gene mspA is regulated in Mycobacterium smegmatis","volume":"189","author":"Dietmar","year":"2007","journal-title":"J Bacteriol"},{"issue":"7","key":"10.1016\/j.tube.2023.102336_bib35","doi-asserted-by":"crossref","first-page":"fnw046","DOI":"10.1093\/femsle\/fnw046","article-title":"Hetero-oligomeric MspA pores in Mycobacterium smegmatis","volume":"363","author":"Pavlenok","year":"2016","journal-title":"FEMS Microbiol Lett"},{"issue":"1","key":"10.1016\/j.tube.2023.102336_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.advms.2015.09.007","article-title":"Pyrazinamide resistance in Mycobacterium tuberculosis: review and update","volume":"61","author":"Njire","year":"2016","journal-title":"Adv Med Sci"},{"issue":"10","key":"10.1016\/j.tube.2023.102336_bib37","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2165\/00003495-200565100-00002","volume":"65","author":"Rubinstein","year":"2005","journal-title":"Tigecycline. Drugs"},{"issue":"10","key":"10.1016\/j.tube.2023.102336_bib38","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1128\/AAC.46.10.3164-3167.2002","article-title":"Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria","volume":"46","author":"Wallace","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"13","key":"10.1016\/j.tube.2023.102336_bib39","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archinte.1997.00440340035003","volume":"157","author":"Joshi","year":"1997","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.tube.2023.102336_bib40","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1073\/pnas.60.4.1479","article-title":"Inhibition of formylmethionyl-transfer RNA binding to ribosomes by tetracycline","volume":"60","author":"Sarkar","year":"1968","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.tube.2023.102336_bib41","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.bmc.2007.01.030","article-title":"Antituberculosis drugs: ten years of research","volume":"15","author":"Janin","year":"2007","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"10.1016\/j.tube.2023.102336_bib42","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1590\/S1806-37132010000500016","article-title":"Antituberculosis drugs: drug interactions, adverse effects, and use in special situations-part 1: first-line drugs","volume":"36","author":"Arbex","year":"2010","journal-title":"J Bras Pneumol"},{"issue":"2","key":"10.1016\/j.tube.2023.102336_bib43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jac\/32.2.195","article-title":"The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli","volume":"32","author":"Mortimer","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.tube.2023.102336_bib44","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1128\/jb.177.4.998-1007.1995","article-title":"Role of outer membrane barrier in efflux-mediated tetracycline resistance of Escherichia coli","volume":"177","author":"Thanassi","year":"1995","journal-title":"J Bacteriol"},{"issue":"3","key":"10.1016\/j.tube.2023.102336_bib45","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1128\/jb.133.3.1181-1189.1978","article-title":"Outer membrane proteins of Escherichia coli VII. Evidence that bacteriophage-directed protein 2 functions as a pore","volume":"133","author":"Pugsley","year":"1978","journal-title":"J Bacteriol"},{"issue":"8","key":"10.1016\/j.tube.2023.102336_bib46","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1128\/JB.184.8.2131-2140.2002","article-title":"Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline","volume":"184","author":"Trieber","year":"2002","journal-title":"J Bacteriol"},{"issue":"17","key":"10.1016\/j.tube.2023.102336_bib47","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1128\/JB.00393-06","article-title":"A mycothiol synthase mutant of Mycobacterium tuberculosis has an altered thiol-disulfide content and limited tolerance to stress","volume":"188","author":"Buchmeier","year":"2006","journal-title":"J Bacteriol"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979223000343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979223000343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:47:44Z","timestamp":1761468464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979223000343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":47,"alternative-id":["S1472979223000343"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2023.102336","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity of tetracycline analogs against multidrug-resistant and extensive drug resistance clinical isolates of Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2023.102336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102336"}}